Results of Biomarck Clinical and Preclinical Studies of BIO-11006
07 Jul 2021 //
BUSINESSWIRE
Results of Biomarck Phase II Study of BIO-11006 in Patients with ARDS
12 May 2021 //
BUSINESSWIRE
Biomarck’s MARCKS Inhibitors for Uveitis to be at the 2021 Annual Meeting
27 Apr 2021 //
BUSINESSWIRE
Biomarck presents at H.C. Wainwright 2021 Global Life Sciences Conference
08 Mar 2021 //
BUSINESSWIRE
Biomarck Pharma to Present Expanded Analysis of BIO-11006 Clinical Data
01 Jun 2020 //
BUSINESSWIRE
Biomarck to Present Expanded Analysis of BIO-11006 Clinical Data in Treatment
01 Jun 2020 //
BUSINESSWIRE